Prevalence of Metabolic Syndrome 32% in Psoriasis Patients
The global prevalence of metabolic syndrome (MetS) is 32% among patients with psoriasis.
Psoriasis
Psoriasis Impacts Characteristics, Treatment of Peripheral Spondyloarthritis
Researchers evaluated the clinical characteristics, disease burden, and treatment of patients with peripheral spondyloarthritis with and without psoriasis.
Predictors of Diagnostic Delay in Psoriasis Identified
Diagnostic delay is common for patients with psoriasis and is increased for men and with psoriasis in specific areas.
Medications Associated With Psoriasis Adverse Events
Researchers sought to investigate medication-related adverse psoriasis events excluding drugs already approved by the US Food and Drug Administration to treat psoriatic arthritis or psoriasis.
TYK2 Inhibitor for the Treatment of Plaque Psoriasis
The efficacy and safety of a once daily oral tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis is assessed.
Psoriasis Affects Health-Related Quality of Life in Pediatric Patients
The role of psoriasis on the health-related quality of life in pediatric patients is investigated.
Psoriasis and the Possibility of Adverse Pregnancy Outcomes
Researchers sought to determine if psoriasis is associated with greater risk of adverse pregnancy outcomes and if psoriasis severity affects the association.
Healthy Lifestyle May Lower Psoriasis Risk, Despite Genetic Predisposition
Researchers explore whether lifestyle is associated with psoriasis onset among individuals with different genetic risk levels.
Risk for Tattoo-Related Complications in Patients With Psoriasis
Researchers investigated the risk for tattoo-related complications among patients with psoriasis.
Psoriasis Tied to Higher Risk for Nonalcoholic Fatty Liver Disease
Psoriasis is associated with nonalcoholic fatty liver disease (NAFLD) in a U.S. outpatient population.
- Loading...
Loading...
Next post in Psoriasis
Loading... 
Loading...